Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
Date:7/30/2013

con's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

 

 Lexicon Pharmaceuticals, Inc.
Selected Financial DataConsolidated Statements of Operations DataThree Months EndedJune 30,Six Months EndedJune 30,(In thousands, except per share data)2013201220132012(unaudited)(unaudited)Revenues:Collaborative research$
211$
99$
495$
351Subscription and license fees3-79148Total revenues214199574499Operating expenses:Research and development, including stock-based compensation of $1,022, $915, $2,352 and $1,952, respectively23,69219,35544,01942,392Increase in fair value of Symphony Icon, Inc. purchase liability4772,1621,7414,243General and administrative, including stock-based compensation of $847, $680, $1,626 and $1,361, respectively4,6694,1628,9938,727Total operating expenses28,83825,67954,75355,362Loss from operations(28,624)(25,480)(54,179)(54,863)Interest income445897114Interest expense(496)(530)(1,002)(1,067)Other income (expense), net(4)213017Consolidated net loss$
(29,080)$  (25,931)$
(55,054)$
(55,799)Consolidated net loss per common share, basic and diluted$  (0.06)$  (0.05)$  (0.11)$  (0.12)Shares used in computing net loss attributable to Lexicon Pharmaceuticals, Inc.  per common share, basic and diluted513,083480,634512,757480,479 Consolidated Balance Sheet DataAs of June 30,As of December 31,(In thousands)20132012(unaudited)Cash and investments

$
75,378$
223,208Property and equipment, net

42,
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lexicon to Report Second Quarter Financial Results on July 30, 2013
2. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
3. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
4. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
5. Lexicon To Present At The Jefferies Global Healthcare Conference
6. Lexicon To Present At The Bank of America Merrill Lynch Healthcare Conference
7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
8. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
9. Lexicon to Report First Quarter Financial Results on May 10, 2013
10. Lexicon To Present At The Needham Healthcare Conference
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
(Date:7/10/2014)... Decision Resources Group finds that over half ... and Drug Administration,s (FDA) approval of Vifor Fresenius Medical ... approved by the FDA in November 2013 for the ... on dialysis. Other key findings from the ... : , Bundling: ...
(Date:1/15/2014)... Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of ... Size, Share, Growth, Trends And Forecast, 2013 - 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables ... to treat dental impairments, for tooth restoration and in ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... schools across the country, teachers are directed to send students ... have a vision issue.  This could be due to the ... the blackboard, poor performance in class or disruptive behavior. The ... difficult and that student could end up in the principal,s ...
... largest professional network for physicians, announced today ... power their medical expert searches. These firms are the ... million in honoraria to physicians last year. Using Doximity,s ... of over 30,000 physician experts. For physicians,  ...
Cached Medicine Technology:Disruptive Students May Not Be Able to See Their Problem 2Disruptive Students May Not Be Able to See Their Problem 3Disruptive Students May Not Be Able to See Their Problem 4Doximity Launches ExpertFinder to Match Clinical Need with Clinical Experts 2
(Date:7/13/2014)... Epidemiologists forecast an increase in the diagnosed incident ... incident cases in 2013 to 11,568 diagnosed incident cases ... 4.35%, during the forecast period. In 2023, the US ... of aGVHD in the 6MM, with 4,989 diagnosed incident ... diagnosed incident cases of aGVHD, with 704 diagnosed incident ...
(Date:7/13/2014)... OH (PRWEB) July 13, 2014 Wright ... bellwether trial has been scheduled in July of 2015, ... Lipitor lawsuits are in the discovery process ... Richard M. Gergel is presiding over the multidistrict litigation ... filed on behalf of individuals who allege that they ...
(Date:7/13/2014)... 13, 2014 Hope Palliative & Hospice Care ... support group at the Tamarack Senior Living Community in Palatine, ... 10:30 A.M. on the 3rd Wednesdays of every month. ... the Tamarack Community located at 55 S. Greeley St. Palatine, ... and there is no cost for the group. , ...
(Date:7/13/2014)... Recently, iFitDress.com, one of the most popular suppliers ... added a new selection of beautiful evening dresses ... a promotion for these evening gowns. Now, everybody can ... providing thousands of graceful gowns in its online store. ... France, Italy and many other countries. They are highly ...
(Date:7/12/2014)... July 12, 2014 The Chicken ... the past five years, buoyed by stable demand for ... management system. “Eggs are a relatively affordable staple for ... egg consumption generally grows in line with the size ... McKitterick. Furthermore, demand for new specialty egg products with ...
Breaking Medicine News(10 mins):Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3
... ... announcing the launch of its new website, Herbal Fen Phen Lawyers ( http://www.herbalfenphenlawyers.com/ ). ... to Fen Phen, despite warnings from the FDA that herbal Fen Phen may be ... attacks, strokes or death. , ...
... efficient to use the drug cetuximab only in colorectal cancer ... a study published online August 7 in the Journal ... tumors harbored wild-type KRAS were found to have a higher ... by the National Cancer Institute of Canada Clinical Trials Group. ...
... BEIJING, Aug. 7 /PRNewswire-Asia-FirstCall/ -- ... CMED ), a leading China-based medical device,company that ... announced the appointment of PricewaterhouseCoopers ("PwC") as,the Company,s ... previous independent auditors, KPMG. , ...
... , Senate Finance Committee Urged Not to ... , WASHINGTON, Aug. 7 America,s local and regional ... a provision imposing a 20% co-pay on laboratory services under Medicare. ... system, this provision would shift billions of dollars in costs to ...
... , MORRISTOWN, N.J., Aug. 7 Watson Pharmaceuticals, ... announced today that one lot of 100 mcg/hr Fentanyl Transdermal System ... wholesalers and pharmacies. The recalled patches are from Lot Number ... Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. The ...
... , NEW YORK, Aug. 7 ... the final results of the previously announced offers by its ... "Issuers"), to purchase for cash (i) any and all of ... Secured Floating Rate Notes due 2010 (the "Floating Rate Notes") ...
Cached Medicine News:Health News:Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website 2Health News:Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website 3Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2Health News:China Medical Technologies Announces Change of Independent Auditors 2Health News:Seniors: Get Your Checkbooks Ready 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 3Health News:Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures 2Health News:Duane Reade Holdings, Inc. Announces Expiration and Results of Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Consents to Related Indentures 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: